VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 1113 · 110th Congress

Inflammatory Bowel Disease Research Enhancement Act

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 110th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

JJD JacksonSponsor
174 cosponsors · 140 D, 34 R
MCR Castle JBD Barrow DDD Davis JGR Gerlach MHD Hinchey PHD Hare SJD Jackson Lee DKD Kildee BLD Lee SLR LaTourette EMD Markey MMD McNulty JMD Moran TMR McCotter GMD Moore END Norton JSD Schakowsky FWR Wolf AWD Weiner BGD Gordon BJR Jindal RBD Brady RGD Grijalva MKD Kaptur PKD Kennedy CMD Maloney JMD McDermott RND Neal PSR Sessions GTD Taylor HWD Waxman GAD Ackerman NDD Dicks PGR Gillmor JMD Marshall JOD Olver NAD Abercrombie SBD Bishop WCD Clay MHD Honda SID Israel WJD Jefferson PMD Murphy DPD Payne JRR Ramstad IRR Ros-Lehtinen SRD Rothman JSR Saxton ETD Towns AWD Wynn DWD Wu SCR Capito EED Engel PKR King NLD Lowey RLR LaHood CPR Pickering CRD Rangel BRD Rush TRD Ryan PSD Stark ECD Cummings BDD Delahunt JAR Ann Davis CFD Fattah KGR Granger RHD Hinojosa DPD Price MSR Souder RWD Wexler GKD Butterfield DCD Christensen JCD Conyers JCD Costello ACR Crenshaw KCR Conaway RDD DeLauro BED Ellsworth BFD Frank EJD Johnson SJD Jones CKD Kilpatrick MKR Kirk JLD Lewis DLD Lipinski BMD McCollum KMD Meek BSD Scott LSD Slaughter DSD Scott MAD Arcuri CBD Brown SBD Berkley JBD Baca MBD Bean BBD Braley JCD Carson JCD Clyburn ECD Cleaver YCD Clarke ADD Davis CED Edwards KED Ellison SFD Farr GGD Green LGD Gutiérrez AGD Green AHD Hastings SHD Herseth Sandlin DIR Issa HJD Johnson DKD Kucinich DLD Loebsack JMD Murtha GMD Meeks LRD Roybal-Allard CRD Rodriguez CRD Ruppersberger LSD Sanchez JSD Serrano BTD Thompson MTD Thompson TUD Udall MWD Waters MWD Watt DWD Watson DBR Burton RRR Renzi CYR Young MBD Berry JAR Ann Emerson ASD Schiff HSD Solis ASD Sires ZWR Wamp TLR Latham CMD McCarthy JMD McGovern BSD Sutton RAD Andrews TBD Baldwin JCD Cooper LCD Capps MCD Capuano RCD Carnahan SDD Davis BED Etheridge RED Emanuel SKD Kagen SLD Lynch CMR Mack DMD Matsui LSD Sánchez CSD Shea-Porter CVD Van Hollen TAD Allen RBR Baker AED Eshoo BFD Filner JAD Altmire BMD Miller SCD Cohen RHD Holt RKD Klein JMR McHugh DMD Moore TMR Murphy JOD Oberstar TDR Drake JHD Hall FLR LoBiondo TBD Bishop MUD Udall ZLD Lofgren

1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Inflammatory Bowel Disease Research Enhancement Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand, intensify, and coordinate the Institute's research activities on inflammatory bowel disease, with an emphasis on: (1) genetic research on susceptibility for inflammatory bowel disease; (2) research…

What it does: CRS summary · Introduced in House · Feb 16, 2007

Inflammatory Bowel Disease Research Enhancement Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand, intensify, and coordinate the Institute's research activities on inflammatory bowel disease, with an emphasis on: (1) genetic research on susceptibility for inflammatory bowel disease; (2) research targeted to increase knowledge about the causes and complications of inflammatory bowel disease in children; (3) animal model research; (4) clinical research; (5) expansion of the Institute's Inflammatory Bowel Disease Centers program with a focus on pediatric research; and (6) other research initiatives identified in specified documents.

Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) develop a system to collect data on pediatric inflammatory bowel disease; (2) establish the National Pediatric IBD Registry; and (3) establish the Advisory Committee on Pediatric Inflammatory Bowel Disease to study and make recommendations relating to the Registry.

Requires the Director of the Centers for Disease Control and Prevention (CDC) to prepare a National Inflammatory Bowel Disease Action Plan to: (1) address the burden of inflammatory bowel disease in both adult and pediatric populations; (2) address strategies for determining the unique demographic, geographic, and environmental-exposure characteristics of the inflammatory bowel disease population; (3) focus on strategies for increasing awareness about the disease within the general public and the health care community; and (4) address mechanisms designed to prevent the progression of the disease and the development of complications.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Inflammatory Bowel Disease Research Enhancement Act

Latest action (Feb 27, 2007): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: Feb 16, 2007

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.